Access cutting-edge non-hodgkin lymphoma treatment through this clinical trial at a research site in Rochester. Study-provided care at no cost to qualified participants.
Access non-hodgkin lymphoma specialists in Rochester at no cost
This study follows strict safety protocols and ethical guidelines
All study-related non-hodgkin lymphoma treatment provided free
The purpose of this study is to define the recommended Phase 2 Dose, safety, tolerability, immunogenicity, and preliminary efficacy of EO2463 during monotherapy and in combination with lenalidomide and/or rituximab in patients with indolent NHL
Sponsor: Enterome
Check if you qualify for this non-hodgkin lymphoma clinical trial in Rochester, MN
If you're searching for non-hodgkin lymphoma treatment options in Rochester, MN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Rochester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-hodgkin lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.